193 related articles for article (PubMed ID: 30754019)
1. Development and validation of LC-MS/MS methods for the quantification of the novel anticancer agent guadecitabine and its active metabolite β‑decitabine in human plasma, whole blood and urine.
Roosendaal J; Wang K; Rosing H; Lucas L; Gebretensae A; Oganesian A; Schellens JHM; Beijnen JH; Lin ZJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1109():132-141. PubMed ID: 30754019
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a HILIC-MS/MS method for quantification of decitabine in human plasma by using lithium adduct detection.
Hua W; Ierardi T; Lesslie M; Hoffman BT; Mulvana D
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 969():117-22. PubMed ID: 25168795
[TBL] [Abstract][Full Text] [Related]
3. Mass balance and metabolite profiling of
Roosendaal J; Rosing H; Lucas L; Gebretensae A; Huitema ADR; van Dongen MG; Beijnen JH; Oganesian A
Invest New Drugs; 2020 Aug; 38(4):1085-1095. PubMed ID: 31605293
[TBL] [Abstract][Full Text] [Related]
4. Development, validation, and clinical application of a high-performance liquid chromatography-tandem mass spectrometry assay for the quantification of total intracellular β-decitabine nucleotides and genomic DNA incorporated β-decitabine and 5-methyl-2'-deoxycytidine.
Roosendaal J; Rosing H; Lucas L; Oganesian A; Schellens JHM; Beijnen JH
J Pharm Biomed Anal; 2019 Feb; 164():16-26. PubMed ID: 30366147
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a liquid chromatography-tandem mass spectrometry method for quantification of decitabine in rat plasma.
Xu H; Lv S; Qiao M; Fu Y; Jiang X; Jin Y; Li C; Yuan B
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun; 899():81-5. PubMed ID: 22626892
[TBL] [Abstract][Full Text] [Related]
6. Liquid chromatography-tandem mass spectrometry assay to quantify plitidepsin in human plasma, whole blood and urine.
van Andel L; Rosing H; Fudio S; Avilés P; Tibben MM; Gebretensae A; Schellens JHM; Beijnen JH
J Pharm Biomed Anal; 2017 Oct; 145():137-143. PubMed ID: 28662481
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous quantitative determination of 5-aza-2'-deoxycytidine genomic incorporation and DNA demethylation by liquid chromatography tandem mass spectrometry as exposure-response measures of nucleoside analog DNA methyltransferase inhibitors.
Anders NM; Liu J; Wanjiku T; Giovinazzo H; Zhou J; Vaghasia A; Nelson WG; Yegnasubramanian S; Rudek MA
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():38-45. PubMed ID: 27082761
[TBL] [Abstract][Full Text] [Related]
8. Quantification of vosaroxin and its metabolites N-desmethylvosaroxin and O-desmethylvosaroxin in human plasma and urine using high-performance liquid chromatography-tandem mass spectrometry.
Nijenhuis CM; Lucas L; Rosing H; Jamieson G; Fox JA; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():1-10. PubMed ID: 27236532
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry assay quantifying olaparib in human plasma.
Nijenhuis CM; Lucas L; Rosing H; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():121-5. PubMed ID: 24145016
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of an LC-MS/MS method for determination of a novel anticancer agent (CPI-613) in human plasma.
Reddy NR; Reddy V; Boteju A; Boteju L; Voelker T; Liu S; Hu K
Bioanalysis; 2022 Mar; 14(5):253-266. PubMed ID: 35172610
[TBL] [Abstract][Full Text] [Related]
11. A robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of 5-azacytidine.
Anders NM; Wanjiku TM; He P; Azad NS; Rudek MA
Biomed Chromatogr; 2016 Mar; 30(3):494-6. PubMed ID: 26174363
[TBL] [Abstract][Full Text] [Related]
12. An HPLC-MS/MS method for simultaneous determination of decitabine and its valyl prodrug valdecitabine in rat plasma.
Zhang Y; Sun J; Gao Y; Kong Y; Xu Y; Jia W; Liao C; Zhang P; Lian H; Han X; Li D; Geng Y; He Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Feb; 917-918():78-83. PubMed ID: 23369881
[TBL] [Abstract][Full Text] [Related]
13. Liquid chromatography-tandem mass spectrometry assay for the quantification of niraparib and its metabolite M1 in human plasma and urine.
van Andel L; Zhang Z; Lu S; Kansra V; Agarwal S; Hughes L; Tibben MM; Gebretensae A; Rosing H; Schellens JHM; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():14-21. PubMed ID: 27898364
[TBL] [Abstract][Full Text] [Related]
14. Quantitative determination of the cytidine deaminase inhibitor tetrahydrouridine (THU) in mouse plasma by liquid chromatography/electrospray ionization tandem mass spectrometry.
Parise RA; Egorin MJ; Eiseman JL; Joseph E; Covey JM; Beumer JH
Rapid Commun Mass Spectrom; 2007; 21(13):1991-7. PubMed ID: 17526067
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of LC-MS/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine.
Dubbelman AC; Tibben M; Rosing H; Gebretensae A; Nan L; Gorman SH; Robertson P; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 893-894():92-100. PubMed ID: 22426286
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of a novel c-Met/AXL dual-target small-molecule inhibitor BPI-9016M and its metabolites in human plasma by liquid chromatography-tandem mass spectrometry: Application in a pharmacokinetic study in Chinese advanced solid tumor patients.
Cui X; Zheng X; Jiang J; Tan F; Ding L; Hu P
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():33-40. PubMed ID: 29028616
[TBL] [Abstract][Full Text] [Related]
17. A validated enantioselective LC-MS/MS assay for quantification of a major chiral metabolite of an achiral 11-β-hydroxysteroid-dehydrogenase 1 inhibitor in human plasma: Application to a clinical pharmacokinetic study.
Furlong MT; Ji QC; Iacono L; Dang O; Noren M; Bruce J; Aubry AF; Arnold ME
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():167-172. PubMed ID: 27100678
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a high-throughput method for the quantitative analysis of D-amphetamine in rat blood using liquid chromatography/MS3 on a hybrid triple quadrupole-linear ion trap mass spectrometer and its application to a pharmacokinetic study.
Cesari N; Fontana S; Montanari D; Braggio S
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(1):21-8. PubMed ID: 19945359
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a liquid chromatography-tandem mass spectrometry analytical method for the therapeutic drug monitoring of eight novel anticancer drugs.
Herbrink M; de Vries N; Rosing H; Huitema ADR; Nuijen B; Schellens JHM; Beijnen JH
Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29165815
[TBL] [Abstract][Full Text] [Related]
20. Validation of high-performance liquid chromatography-tandem mass spectrometry assays quantifying omacetaxine mepesuccinate and its 4'‑des-methyl and cephalotaxine metabolites in human plasma and urine.
Nijenhuis CM; Lucas L; Rosing H; Schellens JH; Beijnen JH; Gorman SH; Burke SM; Campbell DA; Chapple MW; Yousey TH; Mulvana DE
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():152-9. PubMed ID: 26319804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
